Barbara Malanowicz

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Continuous subcutaneous insulin infusion (CSII) is used in selected type 1 diabetic subjects to achieve strict blood glucose control. A quarter of a century after its introduction, worldwide use of CSII is increasing. Review of controlled trials shows that, in most patients, mean blood glucose concentrations and glycated hemoglobin percentages are either(More)
UNLABELLED The aim of the study was to analyse the administration of pre-mixed insulins in the young. We studied 46 type I (insulin-dependent) diabetic subjects aged from 2.5 to 9 years with diabetes duration from 1 to 10 years in a period of 3 years. 19 patients were treated with Novo Nordisk insulins and 27 patients with Lilly pre-mixed insulins during(More)
  • 1